Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

MYLAN-IPRATROPIUM SOLUTION

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MYLAN-IPRATROPIUM SOLUTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MYLAN-IPRATROPIUM SOLUTION 0.25MG has been permanently discontinued (last updated July 4, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MYLAN-IPRATROPIUM SOLUTION not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength0.25MG
Last updated2018-07-04

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

ATROVENT

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

250MCG · DIN 00731439

Different strengthSame dosage formSame routeNo current shortage

NOVO-IPRAMIDE - LIQ 0.25MG/ML

NOVOPHARM LIMITED

.25MG · DIN 02210479

Different strengthSame dosage formSame routeNo current shortage

AA-IPRAVENT

AA PHARMA INC

250MCG · DIN 02126222

Different strengthSame dosage formSame routeNo current shortage

ATROVENT UDV SOL INH 250MCG/ML

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

250MCG · DIN 01950681

Different strengthSame dosage formSame routeNo current shortage

ATROVENT UDV 125MCG/ML

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

125MCG · DIN 02026759

Different strengthSame dosage formSame routeNo current shortage

RATIO-IPRATROPIUM UDV

TEVA CANADA LIMITED

125MCG · DIN 02097176

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02239131

Strength

0.25MG

Dosage Form

SOLUTION

Route

INHALATION

Active Ingredient

IPRATROPIUM BROMIDE

Tier

Unrated

Last Updated

2018-07-04

Reason for Shortage

Business reasons